California Public Employees Retirement System Alnylam Pharmaceuticals, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

A detailed history of California Public Employees Retirement System transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, California Public Employees Retirement System holds 211,781 shares of ALNY stock, worth $49.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

211,781

Previous 215,567 1.76%

Holding current value

$49.6 Million

Previous $52.4 Million 11.21%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$233.81 - $287.01 $885,204 - $1.09 Million	-3,786 Reduced 1.76%	211,781 $58.3 Million
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $177,274 - $305,539	1,237 Added 0.58%	215,567 $52.4 Million
Q1 2024 Apr 30, 2024	BUY	$146.51 - $198.2 $5.13 Million - $6.94 Million	35,000 Added 19.52%	214,330 $32 Million
Q4 2023 Feb 01, 2024	SELL	$151.41 - $196.57 $7.34 Million - $9.53 Million	-48,500 Reduced 21.29%	179,330 $34.3 Million
Q3 2023 Nov 02, 2023	BUY	$170.77 - $211.65 $264,864 - $328,269	1,551 Added 0.69%	227,830 $40.3 Million
Q2 2023 Aug 09, 2023	SELL	$185.01 - $212.05 $2 Million - $2.3 Million	-10,834 Reduced 4.57%	226,279 $43 Million
Q1 2023 May 12, 2023	SELL	$182.66 - $235.53 $6.17 Million - $7.95 Million	-33,770 Reduced 12.47%	237,113 $47.5 Million
Q4 2022 Feb 08, 2023	BUY	$185.53 - $241.31 $208,350 - $270,991	1,123 Added 0.42%	270,883 $64.4 Million
Q3 2022 Nov 09, 2022	BUY	$138.54 - $232.0 $4.6 Million - $7.7 Million	33,205 Added 14.04%	269,760 $54 Million
Q2 2022 Aug 10, 2022	SELL	$120.42 - $169.29 $1.09 Million - $1.53 Million	-9,048 Reduced 3.68%	236,555 $34.5 Million
Q1 2022 May 04, 2022	SELL	$127.18 - $173.91 $8.15 Million - $11.1 Million	-64,072 Reduced 20.69%	245,603 $40.1 Million
Q4 2021 Feb 10, 2022	SELL	$159.56 - $209.29 $1.48 Million - $1.94 Million	-9,284 Reduced 2.91%	309,675 $52.5 Million
Q3 2021 Nov 10, 2021	BUY	$169.75 - $207.73 $215,073 - $263,193	1,267 Added 0.4%	318,959 $60.2 Million
Q2 2021 Aug 13, 2021	SELL	$128.63 - $176.89 $302,923 - $416,575	-2,355 Reduced 0.74%	317,692 $53.9 Million
Q1 2021 May 14, 2021	SELL	$126.83 - $175.69 $1.74 Million - $2.41 Million	-13,693 Reduced 4.1%	320,047 $45.2 Million
Q4 2020 Feb 02, 2021	BUY	$122.97 - $147.0 $8.53 Million - $10.2 Million	69,389 Added 26.25%	333,740 $43.4 Million
Q3 2020 Nov 05, 2020	BUY	$121.19 - $165.49 $1.04 Million - $1.42 Million	8,583 Added 3.36%	264,351 $38.5 Million
Q2 2020 Aug 12, 2020	BUY	$104.21 - $156.44 $3.64 Million - $5.47 Million	34,968 Added 15.84%	255,768 $37.9 Million
Q1 2020 May 12, 2020	SELL	$93.12 - $133.99 $325,920 - $468,965	-3,500 Reduced 1.56%	220,800 $24 Million
Q4 2019 Jan 27, 2020	BUY	$74.51 - $124.23 $3.48 Million - $5.8 Million	46,700 Added 26.3%	224,300 $25.8 Million
Q3 2019 Oct 31, 2019	BUY	$70.9 - $87.82 $3.98 Million - $4.94 Million	56,200 Added 46.29%	177,600 $14.3 Million
Q2 2019 Aug 15, 2019	SELL	$65.86 - $92.79 $3.71 Million - $5.23 Million	-56,386 Reduced 31.72%	121,400 $8.81 Million
Q1 2019 May 03, 2019	SELL	$72.76 - $93.45 $521,907 - $670,316	-7,173 Reduced 3.88%	177,786 $16.6 Million
Q4 2018 Feb 08, 2019	BUY	$62.67 - $88.33 $151,912 - $214,111	2,424 Added 1.33%	184,959 $13.5 Million
Q3 2018 Nov 13, 2018	SELL	$87.52 - $122.67 $2.27 Million - $3.19 Million	-25,979 Reduced 12.46%	182,535 $16 Million
Q2 2018 Aug 15, 2018	SELL	$88.31 - $107.8 $890,606 - $1.09 Million	-10,085 Reduced 4.61%	208,514 $20.5 Million
Q1 2018 May 11, 2018	BUY	$115.92 - $148.54 $2.62 Million - $3.35 Million	22,561 Added 11.51%	218,599 $26 Million
Q4 2017 Feb 06, 2018	BUY	$114.49 - $139.98 $7.19 Million - $8.8 Million	62,832 Added 47.17%	196,038 $24.9 Million
Q3 2017 Nov 15, 2017	BUY	$72.53 - $118.27 $9.66 Million - $15.8 Million	133,206	133,206 $15.7 Million

Others Institutions Holding ALNY

# of Institutions

642

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $28.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account

California Public Employees Retirement System Alnylam Pharmaceuticals, Inc. Transaction History